Please login to the form below

Not currently logged in
Email:
Password:

onartuzumab

This page shows the latest onartuzumab news and features for those working in and with pharma, biotech and healthcare.

Deaths cause Amgen to drop stomach cancer drug

Deaths cause Amgen to drop stomach cancer drug

Another drug acting via the HGF/SF:MET pathway - Roche/Genentech's onartuzumab - suffered a setback earlier this year although in this case the problem was a lack of efficacy in

Latest news

  • Roche drug fails in lung cancer trial Roche drug fails in lung cancer trial

    Damages prospects for onartuzumab. A phase III trial of Roche's cancer prospect onartuzumab has been abandoned after the drug failed to show efficacy. ... In a statement, Roche said it is evaluating the implications of the METLung study results across

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics